BackArbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War) Overview

Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War) EBIT

Track Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War)'s EBIT ($-450B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$505.84K

As of Sep 30, 2022

Annual EBIT (TTM)

-$445.62B

Trailing 12 months ending Sep 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War) (ARCKU) FAQ

Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War)'s ebit stands at $-450B as of September 2022. That is below the sector sector average of $-18M. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War) sits lower the its sector benchmark ($-18M) with a EBIT of $-450B. That is roughly 2527744.2% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Open the history chart to see whether Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War)'s EBIT is expanding or contracting. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Arbor Rapha Capital Bioholdings I - Units (1 Ord Share Class A & 1/3 War)'s EBIT evolved across reporting periods, while the comparison chart places ARCKU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.